These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29727215)

  • 1. Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo.
    Alogna A; Schwarzl M; Manninger M; Hamdani N; Zirngast B; Kloth B; Steendijk P; Verderber J; Zweiker D; Westermann D; Blankenberg S; Maechler H; Tschöpe C; Linke WA; Marsche G; Pieske BM; Post H
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H669-H680. PubMed ID: 29727215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
    Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway.
    Chen L; Zhou X; Deng Y; Yang Y; Chen X; Chen Q; Liu Y; Fu X; Kwan HY; You Y; Jin W; Zhao X
    J Ethnopharmacol; 2023 Jan; 300():115705. PubMed ID: 36099983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased protein phosphatase 5 expression in inflammation-induced left ventricular dysfunction in rats.
    Manilall A; Mokotedi L; Gunter S; Le Roux R; Fourie S; Flanagan CA; Millen AME
    BMC Cardiovasc Disord; 2022 Dec; 22(1):539. PubMed ID: 36494772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
    Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
    J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation.
    Benke K; Németh BT; Sayour AA; Stark KA; Oláh A; Ruppert M; Szabó G; Korkmaz-Icöz S; Horváth EM; Benkő R; Hartyánszky I; Szabolcs Z; Merkely B; Radovits T
    Sci Rep; 2020 Mar; 10(1):5358. PubMed ID: 32210293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.
    Bishu K; Hamdani N; Mohammed SF; Kruger M; Ohtani T; Ogut O; Brozovich FV; Burnett JC; Linke WA; Redfield MM
    Circulation; 2011 Dec; 124(25):2882-91. PubMed ID: 22144574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble guanylate cyclase stimulators in pulmonary hypertension.
    Stasch JP; Evgenov OV
    Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
    Jabs A; Oelze M; Mikhed Y; Stamm P; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Kopp M; Steven S; Schulz E; Stasch JP; Münzel T; Daiber A
    Vascul Pharmacol; 2015 Aug; 71():181-91. PubMed ID: 25869522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
    Næsheim T; How OJ; Myrmel T
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):75-87. PubMed ID: 32662299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load.
    Leite-Moreira AM; Almeida-Coelho J; Neves JS; Pires AL; Ferreira-Martins J; Castro-Ferreira R; Ladeiras-Lopes R; Conceição G; Miranda-Silva D; Rodrigues P; Hamdani N; Herwig M; Falcão-Pires I; Paulus WJ; Linke WA; Lourenço AP; Leite-Moreira AF
    Cardiovasc Res; 2018 Apr; 114(5):656-667. PubMed ID: 29401264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
    Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cyclic guanylate cyclase stimulation on right ventricular hypertrophy and failure alone and in combination with phosphodiesterase-5 inhibition.
    Andersen A; Nielsen JM; Holmboe S; Vildbrad MD; Nielsen-Kudsk JE
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):167-73. PubMed ID: 23575263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
    Kolijn D; Kovács Á; Herwig M; Lódi M; Sieme M; Alhaj A; Sandner P; Papp Z; Reusch PH; Haldenwang P; Falcão-Pires I; Linke WA; Jaquet K; Van Linthout S; Mügge A; Tschöpe C; Hamdani N
    Front Physiol; 2020; 11():345. PubMed ID: 32523538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
    Tsuruda T; Hatakeyama K; Masuyama H; Sekita Y; Imamura T; Asada Y; Kitamura K
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1274-80. PubMed ID: 19684186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery disease.
    Cortese-Krott MM; Mergia E; Kramer CM; Lückstädt W; Yang J; Wolff G; Panknin C; Bracht T; Sitek B; Pernow J; Stasch JP; Feelisch M; Koesling D; Kelm M
    Redox Biol; 2018 Apr; 14():328-337. PubMed ID: 29024896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.
    Krüger M; Kötter S; Grützner A; Lang P; Andresen C; Redfield MM; Butt E; dos Remedios CG; Linke WA
    Circ Res; 2009 Jan; 104(1):87-94. PubMed ID: 19023132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble guanylate cyclase chronic stimulation effects on cardiovascular reactivity in cafeteria diet-induced rat model of metabolic syndrome.
    Doghri Y; Dubreil L; Lalanne V; Hélissen O; Fleurisson R; Thorin C; Desfontis JC; Mallem MY
    Eur J Pharmacol; 2021 May; 899():173978. PubMed ID: 33691164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.